Loading company
Loading
Latest annual · FY2016
Millions- Free cash flow
- 0
Latest quarter · Q3 FY2017
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- (0)
PROTO SCRIPT PHARMACEUTICAL CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $788,960 | $881,442 | -10.5% | 10-K 2017-09-20 · proof |
| Gross profit | $564,470 | $694,295 | -18.7% | 10-K 2017-09-20 · proof |
| Operating income | -$298,083 | -$146,686 | 10-K 2017-09-20 · proof | |
| Net income | $7.2 million | -$145,249 | 10-Q 2018-01-17 · proof | |
| Cash from operating activities | $44,105 | 10-K 2017-09-20 · proof | ||
| Free cash flow | $28,879 | 10-K 2017-09-20 · proof |
- What was PROTO SCRIPT PHARMACEUTICAL CORP's revenue in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported revenue of $788,960 for fiscal 2016 (the year ended Dec 31, 2016), against $881,442 the year before (-10.5%). Source: the 10-K filed with the SEC on Sep 20, 2017. SEC
- What was PROTO SCRIPT PHARMACEUTICAL CORP's gross profit in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported gross profit of $564,470 for fiscal 2016 (the year ended Dec 31, 2016), against $694,295 the year before (-18.7%). Source: the 10-K filed with the SEC on Sep 20, 2017. SEC
- What was PROTO SCRIPT PHARMACEUTICAL CORP's operating income in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported operating income of -$298,083 for fiscal 2016 (the year ended Dec 31, 2016), against -$146,686 the year before. Source: the 10-K filed with the SEC on Sep 20, 2017. SEC
- What was PROTO SCRIPT PHARMACEUTICAL CORP's net income in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported net income of $7.2 million for fiscal 2016 (the year ended Dec 31, 2016), against -$145,249 the year before. Source: the 10-Q filed with the SEC on Jan 17, 2018 (restated). SEC
- What was PROTO SCRIPT PHARMACEUTICAL CORP's cash from operating activities in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported cash from operating activities of $44,105 for fiscal 2016 (the year ended Dec 31, 2016). Source: the 10-K filed with the SEC on Sep 20, 2017. SEC
- What was PROTO SCRIPT PHARMACEUTICAL CORP's free cash flow in fiscal 2016?
- PROTO SCRIPT PHARMACEUTICAL CORP reported free cash flow of $28,879 for fiscal 2016 (the year ended Dec 31, 2016). Source: the 10-K filed with the SEC on Sep 20, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1521420&period_type=annual&limit=5"Information only, not investment advice.